Older Adults (65 Years and Older)Older Adults Without Any Specific Clinical Condition
Investigational drug(s) / intervention(s)
using virtual reality
using virtual reality: Older adults with insomnia in the experimental group will undergo a 20-minute virtual reality session. Data will be collected from elderly adults hospitalized in the internal medicine and surgical clinics of Kars Harakani State Hospital who meet the research criteria. They will be shown 360-degree video images (Chitra and Eremita 2023; Eremita and Chitra 2024) for 20 minutes each night during their hospitalization hours using VR Shinecon virtual reality glasses. One of two 1-hour videos - one with a starry night sky and one with night rain sound - will be selected according to the elderly adults' preference. After each participant's use, the headphone jack of the virtual reality glasses will be wiped with an antiseptic solution. The "Richards-Campbell Sleep Scale (RCSQ)" and the "VAS Comfort Scale (VCS)" will be used to collect data.
Study summary
This research will be conducted to examine the effects of virtual reality on sleep quality and comfort in older adults. This research will be conducted as a single-blind, randomized controlled experimental study with a pre-test-post-test design, involving application and control groups, to examine the effect of virtual reality on sleep quality and comfort in elderly adult patients hospitalized in the internal medicine and surgical clinics of Kars Harakani State Hospital between December 15, 2025, and December 31, 2026. To inform older adults, and after obtaining informed consent, the study will be administered using a "Senior Adult Descriptive Information Form" containing demographic information about older adults, the Standardized Mini Mental Test which assesses the cognitive level of older adults, and a "Senior Adult Monitoring Form" to track any potential side effects of the intervention. The Senior Adult Descriptive Information Form, the Richards-Campbell Sleep Scale (RCSQ), and the VAS Comfort Scale (VCS) will be used to collect data for the study. Data will be collected from elderly adults hospitalized in the internal medicine and surgical clinics of Kars Harakani State Hospital who meet the research criteria. They will be shown 360-degree video images (Chitra and Eremita 2023; Eremita and Chitra 2024) for 20 minutes each night during their hospitalization hours using VR Shinecon virtual reality glasses.
Eligibility
Sex
ALL
Min age
60 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria:
* Older adults willing to participate in the study
* Being 60 years of age or older
* Not having been diagnosed with Parkinson's disease or a psychiatric disorder, not having cognitive impairment, and being able to communicate
* Absence of a sleep apnea diagnosis
* Scoring 24 or higher on the Standardized Mini Mental Test
* The participant stated that her average nightly sleep duration is less than 5 hours
* Avoid using medications that may affect sleep (acetylcholinesterase inhibitors, beta-blockers, diuretics, phenytoin, theophylline, benzodiazepines, etc.)
* Hospital stay must be at least 3 days
* Avoid smoking in the last 15 minutes before a session and avoid using caffeine stimulants (tea/coffee/chocolate/cola etc.) exceeding 1.4 mg/kg in the 10 hours prior.
* Lack of photosensitivity
* Eye disease and absence of contact lenses
Exclusion Criteria:
* Those unwilling to participate in the study
* Those who are not 60 years of age or older
* Patients diagnosed with Parkinson's disease and psychiatric disorders, who have cognitive impairment and are unable to communicate
* Having a diagnosis of sleep apnea
* Those who score below 24 on the Standardized Mini Mental Test
* Those who stated that their average nightly sleep duration is more than 5 hours
* Those who use medication (acetylcholinesterase inhibitor, beta blocker, diuretic, phenytoin, theophylline, benzodiazepine etc.) that can affect sleep
* Hospital stay of 3 days or less
* Smoking a cigarette in the last 15 minutes before a session and using caffeine stimulants (tea/coffee/chocolate/cola etc.) above 1.4 mg/kg 10 hours prior
* Having photosensitivity
* Older adults with eye disease and contact lenses
Primary outcome measure(s)
Sleep quality — 1st midterm test: second day, 2nd midterm test: third day, final test: fourth day Richards-Campbell Sleep Questionnaire: Developed by Richards in 1987, the Richards-Campbell Sleep Questionnaire (RCSQ) is a six-item scale that assesses the depth of nighttime sleep, time to fall asleep, frequency of awakenings, duration of wakefulness, quality of sleep, and ambient noise level. Each item is evaluated on a visual analog scale ranging from 0 to 100. A score of 0-25 indicates very poor sleep, while a score of 76-100 indicates very good sleep. Higher scores indicate improved sleep quality. The Cronbach's α value for the scale developed by Richards is 0.82.
Trial sites (1)
Facility
City
Region
Status
Kafkas University, Faculty of Health Sciences Department of Nursing
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.